22nd Century Other Non-Current Liabilities 2011-2024 | XXII
22nd Century other non-current liabilities from 2011 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
22nd Century Annual Other Non-Current Liabilities
(Millions of US $) |
| 2023 |
$1 |
| 2022 |
$0 |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$0 |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$0 |
| 2015 |
$3 |
| 2014 |
$3 |
| 2013 |
$4 |
| 2012 |
$4 |
| 2011 |
$1 |
| 2010 |
$ |
22nd Century Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2024-09-30 |
$1 |
| 2024-06-30 |
$1 |
| 2024-03-31 |
$1 |
| 2023-12-31 |
$1 |
| 2023-09-30 |
$4 |
| 2023-06-30 |
$6 |
| 2023-03-31 |
$5 |
| 2022-12-31 |
$0 |
| 2022-09-30 |
$1 |
| 2022-06-30 |
|
| 2022-03-31 |
|
| 2021-12-31 |
$0 |
| 2021-09-30 |
$0 |
| 2021-06-30 |
$0 |
| 2021-03-31 |
$0 |
| 2020-12-31 |
$0 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$0 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
$0 |
| 2017-06-30 |
$0 |
| 2017-03-31 |
$0 |
| 2016-12-31 |
$0 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$3 |
| 2015-09-30 |
$3 |
| 2015-06-30 |
$3 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$3 |
| 2014-09-30 |
$3 |
| 2014-06-30 |
$1 |
| 2014-03-31 |
$1 |
| 2013-12-31 |
$4 |
| 2013-09-30 |
$19 |
| 2013-06-30 |
$8 |
| 2013-03-31 |
$9 |
| 2012-12-31 |
$4 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$2 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$3 |
| 2011-06-30 |
$3 |
| 2011-03-31 |
$3 |
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.005B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
